research peptides melanotan 2 MT-2 (Melanotan II) 10 mg
Description
The N-terminal coiled-coil domain is involved in binding and inhibiting both LPL and EL, while the C-terminal fibrinogen domain mediates the angiogenic effects [5]
Whiteford HA, et al
doi:10.1016/j.pathol.2018.11.006
Access this article Similar content being viewed by others Data availability Data is provided within the manuscript or supplementary information files
